Biotech

All Articles

Turnstone gives up 60%, agitates C-suite to extend cash

.Turnstone Biologics is lessening its own headcount by 60% and shocking its own C-suite if you want ...

Gilead quits on $15M MASH bet after mulling preclinical information

.In a year that has viewed a permission as well as a plethora of readouts for metabolic dysfunction-...

Texas biotech centers cancer cells deal, pins hopes on weight problems

.Alaunos Rehabs is actually axing a deal along with Precigen, giving up licensing liberties to an in...

Capricor reveals more information for DMD therapy after launching BLA

.Capricor Therapeutics is taking a success lap for their stage 2 Duchenne muscular dystrophy (DMD) t...

FDA places Kezar lupus trial in hold complying with 4 person fatalities

.The FDA has actually placed Kezar Lifestyle Sciences' lupus test on hold after the biotech flagged ...

Phase 3 Intellectual Stone test hits SMA goal, delivering stockpile 200%

.A phase 3 trial of Historian Rock's vertebral muscle degeneration (SMA) candidate has actually reac...

CAMP 4 is most recent to eye IPO, while Upstream point out $182M planning

.RNA biotech CAMP4 Therapeutics has defined plans for a $67 million IPO, with inflammation-focused U...

Galecto buys leukemia drug, loses bone cancer cells property in pivot

.A year after the breakdown of an idiopathic lung fibrosis applicant sent Galecto on a seek redempti...

Judo throws down $100M to knock out kidney disease

.Taking the mat is actually Judo Biography, an up-and-coming biotech armed with $one hundred thousan...

AstraZeneca spends CSPC $100M for preclinical heart disease medicine

.AstraZeneca has actually paid off CSPC Pharmaceutical Group $one hundred million for a preclinical ...